Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Early in the beginning of the COVID-19 pandemic, scientists predicted the SARS-CoV-2 virus would mutate slowly. They were ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

“This is how viruses evolve. It is not surprising that SARS-CoV2 has become very weak now. It would probably still not be ...

Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

People who later experienced persistent shortness of breath or fatigue after a SARS-CoV-2 infection were already taking ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

Identification of HKU5-CoV-2 (a member of the HKU5 lineage 2), a new merbecovirus found in bats of Zhejiang, Anhui, and ...

HCoV-HKU1, which spreads through respiratory droplets, is less severe than SARS or COVID-19. Experts suggested preventive ...